Skip to main content

Table 2 Summary data on observed copy number variations

From: Identification of genomic copy number variations associated with specific clinical features of head and neck cancer

  # Pathogenic (%) Benign (%) Unknown (%) Log2 range Size range (bp)
Gains 438 321 (73.3%) 24 (5.5%) 93 (21.2%) 0.22 -- 2.82 20,486–155,171,772
Losses 251 162 (64.5%) 26 (10.4%) 63 (25.1%) −3.62 -- -0.25 23,615–127,293,063
  1. 2/64 samples without CNVs: male, oropharynx, stage IVA, pT4pN2, survival time 45 months; female, tongue, stage II, pT2pN0, alive after 40 months